Biocon Biologics  /  Stories  /  Stories – Archive

Stories - Archive

Addressing the COVID-19 Pandemic

The Biocon Group addressed the COVID-19 pandemic unitedly with undeterred spirit and unwavering purpose.

external_link-01
The 10-cent answer to diabetes At 10 cents a day, our insulin is a game changer in the developing world.

Despite the capital-intensive nature of insulin production, Biocon has succeeded in expanding access to insulin therapy in India and key global markets by pursuing an innovation strategy that is rooted in affordability.

external_link-01
Share
buy twitter followers